scholarly article | Q13442814 |
P2093 | author name string | Jonathan R Lindner | |
Albert Sinusas | |||
P2860 | cites work | In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery | Q27339181 |
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein | Q29547752 | ||
Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent. | Q30352821 | ||
Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance | Q30434516 | ||
Multimodality cardiovascular molecular imaging, Part II | Q30438207 | ||
Molecular imaging of the paracrine proangiogenic effects of progenitor cell therapy in limb ischemia | Q30443135 | ||
Dysregulated selectin expression and monocyte recruitment during ischemia-related vascular remodeling in diabetes mellitus | Q30461411 | ||
Molecular Imaging of Activated von Willebrand Factor to Detect High-Risk Atherosclerotic Phenotype | Q30473382 | ||
Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation | Q30484224 | ||
Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease | Q30492960 | ||
Detection of antecedent myocardial ischemia with multiselectin molecular imaging | Q30559110 | ||
Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle | Q31141702 | ||
Prediction of arrhythmic events with positron emission tomography: PAREPET study design and methods | Q33153785 | ||
Monitoring of the biological response to murine hindlimb ischemia with 64Cu-labeled vascular endothelial growth factor-121 positron emission tomography | Q33318187 | ||
Molecular imaging of angiogenic therapy in peripheral vascular disease with alphanubeta3-integrin-targeted nanoparticles | Q34033191 | ||
Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. | Q34077644 | ||
Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo | Q34230328 | ||
Quantitative cardiovascular magnetic resonance for molecular imaging | Q34330885 | ||
Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction | Q34380380 | ||
Matrix metalloproteinases: regulation and dysregulation in the failing heart | Q34574541 | ||
Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction | Q34633720 | ||
Molecular imaging of thrombus: technology in evolution | Q36135602 | ||
Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development | Q36141999 | ||
Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage | Q36204124 | ||
Molecular hybrid positron emission tomography/computed tomography imaging of cardiac angiotensin II type 1 receptors. | Q36467944 | ||
Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. | Q36617730 | ||
Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice | Q36867835 | ||
Molecular imaging in cardiovascular magnetic resonance imaging: current perspective and future potential | Q37002432 | ||
Imaging left ventricular remodeling: targeting the neurohumoral axis | Q37222188 | ||
Diagnostic and prognostic imaging of the cardiac sympathetic nervous system | Q37222196 | ||
Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis | Q37352106 | ||
Multimodality cardiovascular molecular imaging, part I. | Q37609751 | ||
Cardiac sympathetic imaging with mIBG in heart failure | Q37686799 | ||
Cost-effectiveness of coronary CT angiography in evaluation of patients without symptoms who have positive stress test results | Q37735591 | ||
Role of phospholipid oxidation products in atherosclerosis | Q38039282 | ||
Imaging macrophage development and fate in atherosclerosis and myocardial infarction | Q38064660 | ||
Molecular imaging: the key to advancing cardiac stem cell therapy | Q38096580 | ||
High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? | Q38111123 | ||
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology | Q39627320 | ||
Analysis of angiogenesis induced by local IGF-1 expression after myocardial infarction using microSPECT-CT imaging | Q40445265 | ||
Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes | Q41370572 | ||
Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo | Q41612083 | ||
Targeted imaging of the spatial and temporal variation of matrix metalloproteinase activity in a porcine model of postinfarct remodeling: relationship to myocardial dysfunction | Q41829618 | ||
A prospective natural-history study of coronary atherosclerosis | Q41983924 | ||
Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide | Q42402124 | ||
Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study | Q42858853 | ||
Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography | Q42939328 | ||
Imaging of atherosclerosis in apoliprotein e knockout mice: targeting of a folate-conjugated radiopharmaceutical to activated macrophages | Q43097935 | ||
Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study | Q43147933 | ||
Iodofiltic acid I 123 (BMIPP) fatty acid imaging improves initial diagnosis in emergency department patients with suspected acute coronary syndromes: a multicenter trial | Q44275977 | ||
Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles | Q44616397 | ||
Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization | Q45140753 | ||
Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort | Q46107702 | ||
Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction | Q46167122 | ||
Targeting of lectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with 99mTc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque | Q46365505 | ||
Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction. | Q46752654 | ||
Detection of injury-induced vascular remodeling by targeting activated alphavbeta3 integrin in vivo | Q47310860 | ||
Intravascular ultrasound molecular imaging of atheroma components in vivo | Q47972229 | ||
Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling | Q48943251 | ||
Molecular imaging of macrophages in atherosclerotic plaques using bimodal PEG-micelles. | Q50854209 | ||
Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. | Q50970470 | ||
MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor. | Q53524952 | ||
Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis | Q56894441 | ||
In vivo imaging of proteolytic activity in atherosclerosis | Q57188411 | ||
In vivo molecular imaging of angiogenesis, targeting αvβ3 integrin expression, in a patient after acute myocardial infarction | Q60607012 | ||
Imaging human atherosclerosis with 99mTc-labeled low density lipoproteins | Q67967623 | ||
Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse | Q74582629 | ||
Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation | Q78031825 | ||
Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo | Q79792625 | ||
Metabolic imaging for identifying antecedent myocardial ischemia and acute coronary syndrome in the emergency department | Q83053443 | ||
P433 | issue | 6 | |
P921 | main subject | cardiovascular disease | Q389735 |
P304 | page(s) | 990-1001 | |
P577 | publication date | 2013-12-01 | |
P1433 | published in | Journal of Nuclear Cardiology | Q609415 |
P1476 | title | Molecular imaging in cardiovascular disease: Which methods, which diseases? | |
P478 | volume | 20 |
Q49918938 | Endothelial vascular cell adhesion molecule 1 is a marker for high-risk carotid plaques and target for ultrasound molecular imaging |
Q57300751 | Functional probes for cardiovascular molecular imaging |
Q34518372 | Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directions |
Q37592842 | Measurement science in the circulatory system. |
Q52694389 | Molecular Imaging in Drug Discovery and Development. |
Q92424208 | Monoclonal antibody-based molecular imaging strategies and theranostic opportunities |
Q37743798 | Pet Imaging and its Application in Cardiovascular Diseases |
Q89706634 | Ultrasound molecular imaging: insights into cardiovascular pathology |
Q60930311 | multiplex molecular imaging of vascular inflammation using surface-enhanced Raman spectroscopy |
Search more.